Literature DB >> 16690246

[Brain injury during severe sepsis].

A Leon1, C Lepousé, T Floch, J-P Graftieaux.   

Abstract

Sepsis-associated encephalopathy is a global cerebral dysfunction induced by the systemic response to inflammation and infection, without a liver or renal injury. Alteration of consciousness, from confusion to coma, is the main clinical symptom. This encephalopathy is associated with an increase in mortality due to sepsis. Its physiopathology is unknown. There is frequently an increased permeability of the blood-brain barrier, which might explain a role of endotoxins on cerebral metabolism. Changes in neurotransmitter release or concentrations (norepinephrine, serotonin, dopamine, GABA) have been reported. There is not any specific treatment of septic encephalopathy. In most cases, this syndrome is rapidly reversible after the treatment of sepsis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690246     DOI: 10.1016/j.annfar.2006.03.011

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  4 in total

Review 1.  Sepsis-Associated Encephalopathy: from Pathophysiology to Progress in Experimental Studies.

Authors:  Anderson Velasque Catarina; Gisele Branchini; Lais Bettoni; Jarbas Rodrigues De Oliveira; Fernanda Bordignon Nunes
Journal:  Mol Neurobiol       Date:  2021-01-26       Impact factor: 5.590

Review 2.  Pathogenesis of sepsis-associated encephalopathy: more than blood-brain barrier dysfunction.

Authors:  Ke Yang; JinQuan Chen; Ting Wang; Yuan Zhang
Journal:  Mol Biol Rep       Date:  2022-05-31       Impact factor: 2.742

3.  The molecular basis of brain injury in preterm infants with sepsis - associated encephalopathy.

Authors:  Xiaohui Gong; Bowen Weng; Xiaoyue Zhang; Chongbing Yan; Cheng Cai
Journal:  BMC Pediatr       Date:  2022-06-10       Impact factor: 2.567

Review 4.  Septic Encephalopathy.

Authors:  Chiara Robba; Ilaria Alice Crippa; Fabio Silvio Taccone
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-02       Impact factor: 5.081

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.